Clinical Trial Update: A Single-arm Pilot Study of First-line Treatment With Carbognilumab Combined With Chemotherapy in Patients With STK11-mutated Advanced or Postoperative Recurrent Non-small Cell Lung Cancer [Phase 2]

View source ↗

Summary

A Phase 2 single-arm pilot study evaluating first-line carbognilumab in combination with chemotherapy for STK11-mutated advanced or postoperative recurrent non-…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Carbognilumab (carbognilumab)

Snippet

Sponsor: Guangzhou Institute of Respiratory Disease | Conditions: Non-small Cell Lung Cancer | Phase 2 | Status: UNKNOWN